Question explored with the scientific record
Explain DMSO
DMSO is a real, versatile solvent with genuine medical uses, but its reputation as a cure-all far outruns the evidence.
DMSO (dimethyl sulfoxide) is a chemical solvent that easily crosses skin. Its main proven medical roles are as a penetration enhancer, helping other drugs absorb through skin, and as a cryoprotectant, protecting cells during freezing [1][3]. A 1986 study showed DMSO dramatically increased skin penetration of acyclovir and idoxuridine compared to standard ointments [9]. It is also used as an intravesical treatment for interstitial cystitis, with older studies reporting high response rates, though a 2016 randomized trial found it less effective and more irritating than hyaluronic acid plus chondroitin sulfate [5][6].
The evidence for its other claimed benefits is mixed. A 2024 review noted anti-inflammatory effects in mouse models and wound healing at low concentrations, but higher concentrations delayed healing [1]. A 2008 rabbit study found DMSO attenuated, but did not abolish, LPS-induced fever [2]. A 2009 trial showed topical interferon with DMSO sped up viral shedding cessation in genital herpes, but the study was tiny (20 patients) [4].
Safety data from a systematic review of 109 studies shows mostly mild, transient reactions: nausea in about 12 in 100, vomiting in 7 in 100, and skin burning in 16 in 100 [8]. Garlic-like breath is the only effect solely attributable to DMSO, occurring in about 11 in 100 [8]. Cardiac reactions occurred only with intravenous use [7]. The 2025 review of DMSO in stem cell products concluded no significant safety concerns under current clinical use [3].
| Route | Nausea | Vomiting | Skin burning |
|---|---|---|---|
| Intravenous | 17% | - | - |
| Transdermal | 5% | - | 16% |
| Overall | 12% | 7% | - |
The main caveat: most evidence is from small studies, animal models, or reviews of heterogeneous data. No large, long-term human trials compare DMSO against placebo for most conditions.
My call: DMSO is a legitimate penetration enhancer and cryoprotectant with modest anti-inflammatory effects, but the evidence does not support it as a broad-spectrum cure. Confidence: moderate.
Sources used 9
-
Dimethyl sulfoxide in topical pharmaceutical drug development: A fresh perspective
A narrative review proposes that high-purity (>99.99%) DMSO is an effective, underused topical penetration enhancer with anti-inflammatory and analgesic activity, and that higher purity may reduce the halitosis historically associated with topical DMSO.
DOI: 10.66617/001c.120609 -
Dimethyl sulfoxide effects on the febrile response to lipopolysaccharide injection in rabbits
In rabbits, intravenous DMSO given before LPS significantly attenuated but did not abolish the LPS-induced febrile response, delaying onset and replacing the typical biphasic fever with a less intense, sustained temperature increase.
DOI: 10.1590/s0102-09352008000300016 -
Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients?
This study reviews published safety data on dimethyl sulfoxide (DMSO) used as a cryoprotectant in DMSO-containing cryopreserved mesenchymal stem/stromal cell (MSC) products administered intravenously or topically, evaluating patient safety risks and concluding no significant saf…
DOI: 10.1186/s12967-025-06807-6 -
Topical Alpha-lnterferon Ointment with Dimethyl Sulfoxide in the Treatment of Recurrent Genital Herpes simplex
Topical alpha-interferon ointment with dimethyl sulfoxide significantly increased day-1 cessation of viral shedding in recurrent genital herpes versus placebo, and showed nonsignificant reductions in recurrences and faster lesion healing.
DOI: 10.1159/000247497 -
Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review
This review evaluates the efficacy and application of dimethyl sulfoxide (DMSO) as an intravesical therapy for interstitial cystitis/bladder pain syndrome, highlighting variable response rates and the need for standardized treatment protocols.
DOI: 10.1002/nau.23204 -
A randomized, open‐label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis
In a phase III randomized multicenter trial in 110 women with bladder pain syndrome/interstitial cystitis, intravesical hyaluronic acid plus chondroitin sulfate (Ialuril) was compared with dimethyl sulfoxide (DMSO); HA/CS achieved similar pain reduction with a more favorable saf…
DOI: 10.1002/nau.23091 -
Adverse reactions of dimethyl sulfoxide in humans: a systematic review
In a systematic review of 109 studies, DMSO was associated with mostly transient, mild adverse reactions, most commonly gastrointestinal and skin reactions, with reaction occurrence appearing dose-related.
DOI: 10.12688/f1000research.16642.2 -
Adverse reactions of dimethyl sulfoxide in humans: a systematic review
In a systematic review of 109 studies, DMSO adverse reactions in humans were most often gastrointestinal and dermatological, mostly transient and mild; occurrence appeared dose-related, and DMSO seemed safe in small doses.
DOI: 10.12688/f1000research.16642.1 -
Failure of topical acyclovir in ointment to penetrate human skin
This study demonstrates that topical acyclovir in polyethylene glycol ointment penetrates human skin poorly, while reformulation in modified aqueous cream or dimethyl sulfoxide markedly enhances skin delivery of acyclovir (and idoxuridine), with implications for topical HSV ther…
DOI: 10.1128/AAC.29.5.730